Migraine could be considered a clinical marker of increased obstetric risk in pregnant women.
This is the largest known study to consider medical and recreational cannabis policies with US psychosis-related health care claims.
The supplemental new drug application is based on results from a landmark phase 3 trial showing that empagliflozin tablets provided meaningful results.
The vaccine was 88% effective at preventing pertussis among infants younger than 2 months when administered during the third trimester of pregnancy.
The number of Mpox cases is expected to rise, which requires ongoing testing, vaccinations, and medication services by health care providers.
Intravenous tocilizumab (Actemra; Genentech) has been approved for the treatment of COVID-19 in individuals who are hospitalized and receiving systemic corticosteroids and supplemental oxygen.
There are limited data on the efficacy of boosters for preventing infection and death in nursing home residents, but the findings suggest that boosters may have significantly reduced COVID-19–associated morbidity and mortality in this population.
Booster shots updated for the Omicron variant BA.4 and BA.5 lineages cleared for children 6 months through 4 years of age.
Parties and get-togethers often present challenges for patients with allergies, particularly with home-cooked food that may have unclear ingredients.
Although long-term health issues from COVID-19 are a major public health concern, evidence on post-COVID-19 symptoms are still limited, specifically among children and adolescents.